Page 163 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 vaccine approval: Why is it taking so long? | India News

An employee in PPE removes vials of Covishield from a visual inspection machine inside a lab at Serum Institute of India, Pune NEW DELHI: Britain on Wednesday became the first country to give emergency use authorisation (EUA) to the Oxford University-AstraZeneca Covid-19 vaccine. The move clears the path for a cheap and easy-to-store shot that much of the world will rely on to help end the pandemic. Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% eff… https://t.co/rz4SJmlDgt University of Oxford (@UniofOxford) 1606115164000 Back home, Pune-based Serum Institute of India (SII) has sought emergency approval for the vaccine Covishield developed along with AstraZeneca and Oxford University.

United kingdomAstrazeneca covidHarsh vardhanRajesh bhushanCentral licencing authorityDrug administrationIndian council of medical researchCentral drugs standard control organisationSerum institute of indiaOxford universityUniversity of oxford uniofoxfordSerum instituteOxford university astrazenecaPune based serum instituteBharat biotechIndian council

COVID-19 vaccine: India will have a happy New Year with something in hand, says DCGI

COVID-19 vaccine: India will have a happy New Year with something in hand, says DCGI
mid-day.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mid-day.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAstrazeneca covidZydus cadilaCentral drugs standard control organisationBharat biotech privateBharat biotechHealthcare regulatory agencyExpert committeeSerum institute of indiaOxford universityDrug controller generalSerum instituteController generalSubject expert committeeEmergency use authorisation

India Seeks to Export COVID-19 Vaccines to Arab States

Thursday, 31 December, 2020 - 09:30 Members of ground staff walk past a container stacked at the Indira Gandhi International Airport, which will be used as a Covid-19 coronavirus vaccines handling and distribution center. (AFP) New Delhi - Asharq Al-Awsat India is seeking to export coronavirus vaccines to Arab countries. Indian companies are currently producing the vaccine in accordance with the international standards, said Indian experts and observers, who are based in Dubai. The southern Indian city of Hyderabad’s Bharat Biotech, the Pune-based Serum Institute of India (SII) and the US-based Pfizer are producing the expected COVID-19 vaccine, the German news agency reported on Wednesday.

United arab emiratesFahim ahmedUnited nations children fundWorld health organizationSerum institute of indiaRussian direct investment fundBharat biotechPune based serum instituteUnited nations childrenDubai based indianஒன்றுபட்டது அரபு அமீரகங்கள்ஒன்றுபட்டது நாடுகள் குழந்தைகள் நிதிஉலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்சீரம் நிறுவனம் ஆஃப் இந்தியாரஷ்ய நேரடி முதலீடு நிதிபாரத் பயோடெக்

Covid vaccine: Singapore starts Covid-19 vaccination exercise, Health News, ET HealthWorld

Covid vaccine: Singapore starts Covid-19 vaccination exercise, Health News, ET HealthWorld
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Harsh vardhanUnion healthSerum institute of indiaPune based serum instituteUnion health minister harshகடுமையான வர்தன்தொழிற்சங்கம் ஆரோக்கியம்சீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்தொழிற்சங்கம் ஆரோக்கியம் அமைச்சர் கடுமையான

Happy New Year with something in hand: DCGI hints at COVID vaccine approval soon

Pakistan s genius doctor says eating popcorn builds COVID immunity As India awaits with bated breath for a silver bullet against coronavirus, the Drug Controller General of India (DCGI) on Thursday hinted at the approval of vaccine and said the country will have a happy new year with something in hand. The drug regulator is currently analysing the data submitted by Serum Institute of India, which is manufacturing Oxford-AstraZeneca vaccine and Bharat Biotech, which is making indigenous vaccine in collaboration with ICMR. The expert panel will convene a meeting on January 1 on this. The industry and research organisation have stood the test of time. It has been a very wonderful experience. Probably, we will have a happy new year with something in hand. That is what I can hint at, Drug Controller General of India (DCGI) V.G. Somani said.

United statesUnited kingdomAstrazeneca covidZydus cadilaCentral drugs standard control organisationBharat biotech privateBharat biotechHealthcare regulatory agencySerum institute of indiaOxford universityExpert committeeDrug controller generalSerum instituteController generalSubject expert committeeEmergency use authorisation